Kumar Dharmarajan1,2, Kelly M Strait2, Mary E Tinetti3,4, Tara Lagu5,6,7, Peter K Lindenauer5,6,7, Joanne Lynn8, Michelle R Krukas9, Frank R Ernst9, Shu-Xia Li2, Harlan M Krumholz1,2,10,11. 1. Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut. 2. Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut. 3. Section of Geriatrics, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut. 4. Section of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, Connecticut. 5. Center for Quality of Care Research, Baystate Medical Center, Springfield, Massachusetts. 6. Division of General Internal Medicine, Baystate Medical Center, Springfield, Massachusetts. 7. Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts. 8. Altarum Institute, Washington, District of Columbia. 9. Premier Research Services, Premier, Inc., Charlotte, North Carolina. 10. Section of Health Policy and Administration, Yale University School of Public Health, New Haven, Connecticut. 11. Robert Wood Johnson Clinical Scholars Program, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Abstract
OBJECTIVES: To determine how often hospitalized older adults principally diagnosed with pneumonia, chronic obstructive pulmonary disease (COPD), or heart failure (HF) are concurrently treated for two or more of these acute cardiopulmonary conditions. DESIGN: Retrospective cohort study. SETTING: 368 U.S. hospitals in the Premier research database. PARTICIPANTS: Individuals aged 65 and older principally hospitalized with pneumonia, COPD, or HF in 2009 or 2010. MEASUREMENTS: Proportion of diagnosed episodes of pneumonia, COPD, or HF concurrently treated for two or more of these acute cardiopulmonary conditions during the first 2 hospital days. RESULTS: Of 91,709 diagnosed pneumonia hospitalizations, 32% received treatment for two or more acute cardiopulmonary conditions (18% for HF, 18% for COPD, 4% for both). Of 41,052 diagnosed COPD hospitalizations, 19% received treatment for two or more acute cardiopulmonary conditions (all of which involved additional HF treatment). Of 118,061 diagnosed HF hospitalizations, 38% received treatment for two or more acute cardiopulmonary conditions (34% for pneumonia, 9% for COPD, 5% for both). CONCLUSION: Hospitalized older adults diagnosed with pneumonia, COPD, or HF are frequently treated for two or more acute cardiopulmonary conditions, suggesting that clinical syndromes often fall between traditional diagnostic categories. Research is needed to evaluate the risks and benefits of real-world treatment for the many older adults whose presentations elicit diagnostic uncertainty or concern about coexisting acute conditions.
OBJECTIVES: To determine how often hospitalized older adults principally diagnosed with pneumonia, chronic obstructive pulmonary disease (COPD), or heart failure (HF) are concurrently treated for two or more of these acute cardiopulmonary conditions. DESIGN: Retrospective cohort study. SETTING: 368 U.S. hospitals in the Premier research database. PARTICIPANTS: Individuals aged 65 and older principally hospitalized with pneumonia, COPD, or HF in 2009 or 2010. MEASUREMENTS: Proportion of diagnosed episodes of pneumonia, COPD, or HF concurrently treated for two or more of these acute cardiopulmonary conditions during the first 2 hospital days. RESULTS: Of 91,709 diagnosed pneumonia hospitalizations, 32% received treatment for two or more acute cardiopulmonary conditions (18% for HF, 18% for COPD, 4% for both). Of 41,052 diagnosed COPD hospitalizations, 19% received treatment for two or more acute cardiopulmonary conditions (all of which involved additional HF treatment). Of 118,061 diagnosed HF hospitalizations, 38% received treatment for two or more acute cardiopulmonary conditions (34% for pneumonia, 9% for COPD, 5% for both). CONCLUSION: Hospitalized older adults diagnosed with pneumonia, COPD, or HF are frequently treated for two or more acute cardiopulmonary conditions, suggesting that clinical syndromes often fall between traditional diagnostic categories. Research is needed to evaluate the risks and benefits of real-world treatment for the many older adults whose presentations elicit diagnostic uncertainty or concern about coexisting acute conditions.
Authors: Vicente F Corrales-Medina; Daniel M Musher; George A Wells; Julio A Chirinos; Li Chen; Michael J Fine Journal: Circulation Date: 2012-01-04 Impact factor: 29.690
Authors: G Michael Felker; Kerry L Lee; David A Bull; Margaret M Redfield; Lynne W Stevenson; Steven R Goldsmith; Martin M LeWinter; Anita Deswal; Jean L Rouleau; Elizabeth O Ofili; Kevin J Anstrom; Adrian F Hernandez; Steven E McNulty; Eric J Velazquez; Abdallah G Kfoury; Horng H Chen; Michael M Givertz; Marc J Semigran; Bradley A Bart; Alice M Mascette; Eugene Braunwald; Christopher M O'Connor Journal: N Engl J Med Date: 2011-03-03 Impact factor: 91.245
Authors: Peter K Lindenauer; Sharon-Lise T Normand; Elizabeth E Drye; Zhenqiu Lin; Katherine Goodrich; Mayur M Desai; Dale W Bratzler; Walter J O'Donnell; Mark L Metersky; Harlan M Krumholz Journal: J Hosp Med Date: 2011-01-05 Impact factor: 2.960
Authors: R Graham Barr; David A Bluemke; Firas S Ahmed; J Jeffery Carr; Paul L Enright; Eric A Hoffman; Rui Jiang; Steven M Kawut; Richard A Kronmal; João A C Lima; Eyal Shahar; Lewis J Smith; Karol E Watson Journal: N Engl J Med Date: 2010-01-21 Impact factor: 91.245
Authors: Judith H Lichtman; John A Spertus; Kimberly J Reid; Martha J Radford; John S Rumsfeld; Norrina B Allen; Frederick A Masoudi; William S Weintraub; Harlan M Krumholz Journal: Circulation Date: 2007-10-08 Impact factor: 29.690
Authors: Harish Jasti; Eric M Mortensen; David Scott Obrosky; Wishwa N Kapoor; Michael J Fine Journal: Clin Infect Dis Date: 2008-02-15 Impact factor: 9.079
Authors: Polliana B Dos Santos; Rodrigo P Simões; Cássia da L Goulart; Meliza G Roscani; Renan S Marinho; Patrícia Faria Camargo; Renata F Arbex; Guilherme Casale; Cláudio R Oliveira; Renata G Mendes; Ross Arena; Audrey Borghi-Silva Journal: Int J Chron Obstruct Pulmon Dis Date: 2021-02-03
Authors: Thomas C Booth; Gerard Thompson; Helen Bulbeck; Florien Boele; Craig Buckley; Jorge Cardoso; Liane Dos Santos Canas; David Jenkinson; Keyoumars Ashkan; Jack Kreindler; Nicky Huskens; Aysha Luis; Catherine McBain; Samantha J Mills; Marc Modat; Nick Morley; Caroline Murphy; Sebastian Ourselin; Mark Pennington; James Powell; David Summers; Adam D Waldman; Colin Watts; Matthew Williams; Robin Grant; Michael D Jenkinson Journal: Front Oncol Date: 2021-02-09 Impact factor: 6.244
Authors: Thomas C Booth; Evita C Wiegers; Esther A H Warnert; Kathleen M Schmainda; Frank Riemer; Ruben E Nechifor; Vera C Keil; Gilbert Hangel; Patrícia Figueiredo; Maria Del Mar Álvarez-Torres; Otto M Henriksen Journal: Front Oncol Date: 2022-02-28 Impact factor: 5.738
Authors: Lilas Ali; Sara Wallström; Emmelie Barenfeld; Andreas Fors; Eva Fredholm; Hanna Gyllensten; Karl Swedberg; Inger Ekman Journal: BMJ Open Date: 2020-07-19 Impact factor: 2.692